Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFUSE-Morphine
NCT00593281Phase 3Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- Jan 2006
- Primary completion
- Oct 2006
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of hyaluronidase in pain, sponsored by Halozyme Therapeutics, Inc.. Started Jan 2006; status: completed.
02
Drugs
hyaluronidase
03
Conditions
pain
Beyond the preview
Go deeper on NCT00593281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593281.